Related Experiment Videos
[Combined Wilms' tumor therapy (author's transl)]
Strahlentherapie
|January 1, 1980
Summary
Wilms' tumor treatment evolved, with newer protocols improving survival rates. Modern Wilms' tumor therapy, combining chemotherapy, surgery, and adjusted irradiation, significantly enhances patient outcomes.
Area of Science:
- Pediatric Oncology
- Radiation Oncology
- Surgical Oncology
Context:
- Wilms' tumor is a common pediatric kidney cancer.
- Treatment protocols have evolved over time.
- Therapeutic strategies impact patient survival rates.
Purpose:
- To evaluate the effectiveness of evolving Wilms' tumor treatment protocols.
- To compare outcomes between different therapeutic approaches.
- To identify optimal treatment strategies based on patient age and tumor stage.
Summary:
- Early treatment (1967-1972) involved preoperative irradiation (20 Gy), surgery, and actinomycin-D, with postoperative irradiation (20-30 Gy). This yielded a 71.4% survival rate (15/22 survivors).
- Later treatment (since 1973) adapted based on age and tumor volume, incorporating multidrug therapy, surgery, and 25-35 Gy irradiation.
- The adapted protocol resulted in an 94.7% survival rate (18/19 survivors), with irradiation omitted for specific early-stage or young patients.
Impact:
- The study highlights the importance of tailored therapeutic strategies in pediatric oncology.
- Adjusting irradiation doses and timing significantly improves survival in Wilms' tumor patients.
- The findings support the current trend towards less toxic and more personalized cancer treatments for children.